Filing Flows › RXO (RXO) › Q4 2025
RXO (RXO) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 9, 2026
RXO (RXO) reported revenue of $1.5B for the fourth quarter 2025 (Q4 2025), -12% from a year earlier and +3% from the quarter before. Operating margin was -2.9%, net loss $46.0M (3.1% of revenue).
RXO, Q4 2025: revenue $1.5B (-12% year over year), operating margin -2.9%, net loss $46.0M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | +3% | -12% |
| Operating profit | −$42.0M | — | — |
| Net earnings | −$46.0M | — | — |
| Operating cash flow | $7.0M | -70% | — |
What changed
Revenue was $1.5B in Q4 2025, down 12% year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $0.04B, an operating margin of -2.9%. Total costs fell 11% while revenue fell 12%. The quarter ended with a net loss of $0.05B, wider than the previous quarter's $0.01B loss.
Operating cash flow was $0.01B. Non-cash charges added back $0.03B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.02B. Capital expenditures of $0.02B exceeded it, leaving free cash flow of −$0.01B.
Questions
What was RXO's revenue in the fourth quarter 2025?
RXO (RXO) reported revenue of $1.5B for the fourth quarter 2025 (Q4 2025), -12% from a year earlier and +3% from the quarter before.
Was RXO profitable in the fourth quarter 2025?
Operating loss was $42.0M (-2.9% of revenue) and net loss $46.0M.
Source: RXO 10-K on SEC EDGAR.